Orchard Therapeutics plc (ORTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

108 CANNON STREET LONDON, UNITED KINGDOM EC4N 6EU

Orchard Therapeutics PLC operates as biopharmaceutical company. The Company offers medical research, gene therapy, and inherited disorder treatment services. Orchard Therapeutics serves customers worldwide.

Data based on most recent fiscal year report
Market Cap1.35 Billion Shares Outstanding96.19 Million Avg Volume257.117 Thousand
1-Yr BETA vs S&P TR0.486 Current Ratio7.42 Quick Ratio7.42
View SEC Filings from ORTX instead.

View recent insider trading info

Funds Holding ORTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.9 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

4.9 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALTSCHULER STEVEN

  • Director
0 2020-03-23 2

SECOR ALICIA

  • Director
16,440 2020-03-02 1

GASPAR BOBBY SEE REMARKS

  • Officer
  • Director
352,319 2020-03-02 3

FMR LLC

  • 10% Owner
  • SEE REMARK 1
6,971,912 2020-02-10 2

GERAGHTY JAMES A

0 2020-01-25 1

THOMAS FRANK E SEE REMARKS

  • Officer
0 2020-01-02 2

ROWLAND CHARLES A JR

  • Director
0 2020-01-02 1

DUNOYER MARC

  • Director
37,179 2020-01-01 1

CURNUTTE JOHN T

  • Director
0 2020-01-01 1

BECK JOANNE T.

  • Director
9,294 2020-01-01 1

ELLIS JON

  • Director
0 2020-01-01 1

ROTHERA MARK SEE REMARKS

  • Officer
  • Director
103,796 2020-01-01 1

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GASPAR BOBBY - Director - Officer SEE REMARKS

2020-03-02 S 4,921 $13.00 d 348,319 352,319.00 direct yes

GASPAR BOBBY - Director - Officer SEE REMARKS

2020-03-02 M 4,921 $0.00 a 353,240 352,319.00 direct yes

GASPAR BOBBY - Director - Officer SEE REMARKS

2020-03-02 M 4,921 d 597,867 352,319.00 direct

ALTSCHULER STEVEN - Director

2020-02-03 A 50,000 a 50,000 0.00 direct

Elevate your investments